Michael Steinmetz files SEC Form 4 disclosures for Pharmasset Inc. They have made 8 open-market trades across 7 companies since 2006, most recently 2012-06-19.
CIK 0001166285
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $5.0M since 2006, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SOMX | SELL | 2012-06-19 | 2012-06-21 | $0.29 | $3K | N/A | N/A | N/A |
| ZLCS | SELL | 2011-10-13 | 2011-10-17 | $1.02 | $46K | N/A | N/A | N/A |
| ZLCS | SELL | 2011-10-07 | 2011-10-11 | $1.03 | $523K | N/A | N/A | N/A |
| ACHN | BUY | 2008-09-05 | 2008-09-09 | $2.25 | $10K | -25.7% | -1.9% | -1.9% |
| VRUS | SELL | 2008-06-19 | 2008-06-23 | $19.90 | $3.1M | N/A | N/A | N/A |
| HAQ | BUY | 2007-08-07 | 2007-08-07 | $7.70 | $963K | N/A | N/A | N/A |
| HLCS | BUY | 2007-05-30 | 2007-05-31 | $9.00 | $3.0M | N/A | N/A | N/A |
| ACOR | BUY | 2006-02-15 | 2006-02-17 | $6.00 | $1.0M | -8.7% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| — |
| ZLCS | 12,995,229 | — |
| Total | $37.1M |